Bran E López, Pérez L Pozo, Esteban P Tornero, Morales M L González
Dermatology Department, Hospital Clínico San Carlos, Madrid, Spain.
Institute for Health Research of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Stem Cell Res Ther. 2025 Jun 7;16(1):292. doi: 10.1186/s13287-025-04372-9.
Androgenetic alopecia (AGA), also known as male or female pattern hair loss, is the most prevalent form of alopecia worldwide. Current treatments are based on hormone drugs, topical vasodilators and hair transplants. Newer options include stem cell therapy targeted at recovering the capacity for hair follicle regeneration. This study examines the effects of intradermally administering allogenic adipose-derived stem cells (ASCs) per se or supplemented with ATP in a mouse model of dihydrotestosterone (DHT)-induced AGA.
Male and female C57BL6-strain mice were treated with DHT to induce AGA and then given injections of treatment solution in a defined area of the depilated back skin, and the same injections three days later. The treatments tested were several concentrations of ASCs combined with two ATP formulations. Photographs of the treated zones were taken on days 7, 10, 14, 17 and 21 and subjected to Image J analysis. On day 21, skin samples were also obtained for histological analysis. The main outcome measure was percentage treated surface area showing hair regrowth on treatment days 17 and 21 expressed as five categories: null, poor, moderate, intense and complete (20, 40, 60, 80 and 100% respectively).
The experimental groups found to show the highest number of male individuals with intense/complete hair regrowth on day 21 were those in which mice received low dose ASCs (1 ∙ 10) combined either with liposomal ATP or non-liposomal ATP. Both these groups showed significant differences compared to controls. In females, while low dose ASC treatments and the high dose ASC + liposomal ATP treatment led to no hair regrowth improvement over the control treatment, medium dose ASC (2 × 10) + non-liposomal ATP gave rise to greater regrowth scores.
Hair regrowth was improved in all experimental groups in which male mice were administered stem cell solutions supplemented with ATP. In female mice, the highest hair regrowth scores were observed for the medium dose ASC + liposomal ATP treatment.
雄激素性脱发(AGA),也称为男性或女性型脱发,是全球最常见的脱发形式。目前的治疗方法基于激素药物、局部血管扩张剂和毛发移植。新的治疗选择包括旨在恢复毛囊再生能力的干细胞疗法。本研究在二氢睾酮(DHT)诱导的AGA小鼠模型中,研究了皮内注射异体脂肪来源干细胞(ASC)本身或补充ATP后的效果。
用DHT处理雄性和雌性C57BL6品系小鼠以诱导AGA,然后在脱毛背部皮肤的特定区域注射治疗溶液,并在三天后进行相同注射。测试的治疗方法是几种浓度的ASC与两种ATP制剂的组合。在第7、10、14、17和21天拍摄治疗区域的照片,并进行Image J分析。在第21天,还获取皮肤样本进行组织学分析。主要观察指标是在治疗第17天和21天显示毛发再生的治疗表面积百分比,分为五类:无、差、中度、重度和完全(分别为20%、40%、60%、80%和100%)。
在第21天发现雄性个体毛发再生强度/完全再生数量最多的实验组是接受低剂量ASC(1∙10)与脂质体ATP或非脂质体ATP联合治疗的小鼠组。与对照组相比,这两组均显示出显著差异。在雌性小鼠中,虽然低剂量ASC治疗和高剂量ASC +脂质体ATP治疗与对照治疗相比没有导致毛发再生改善,但中剂量ASC(2×10)+非脂质体ATP产生了更高的再生分数。
在所有给雄性小鼠施用补充ATP的干细胞溶液的实验组中,毛发再生均得到改善。在雌性小鼠中,中剂量ASC +脂质体ATP治疗观察到最高的毛发再生分数。